L. Elkin

发表

DMD054205 566..574

A. D. Rodrigues, Y. Lai, M. Cvijic, 2014 .

Development of an LC-MS/MS method for high throughput quantification of metformin uptake in transporter inhibition assays.

Jun Zhang, W. Shou, H. Weller, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Inhibitor scaffolds as new allele specific kinase substrates.

K. Shokat, D. Morgan, J. Blethrow, 2002, Journal of the American Chemical Society.

Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain*

Stephen R. Johnson, M. Witmer, J. Tokarski, 2015, The Journal of Biological Chemistry.

Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.

J. Hunt, S. P. Seitz, K. Covello, 2017, Bioorganic & medicinal chemistry letters.

Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality

L. L. Elkin, D. G. Harden, S. Saldanha, 2015, Journal of biomolecular screening.

Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump

A. D. Rodrigues, Y. Lai, M. Cvijic, 2014, Drug Metabolism and Disposition.

Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump

Y. Lai, M. Cvijic, T. Zvyaga, 2014, Drug Metabolism and Disposition.

Microsoft Word-25615913-file00.docx

A. D. Rodrigues, Y. Lai, M. Cvijic, 2013 .

Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4.

D. Brittelli, R. Desimone, K. Currie, 2009, Bioorganic & medicinal chemistry letters.

Application of an in vitro OAT assay in drug design and optimization of renal clearance

P. Barton, R. Riley, M. Soars, 2014, Xenobiotica; the fate of foreign compounds in biological systems.

Abstract 17: Preclinical and phase 1 trial results of JI-101, a novel, oral tyrosine kinase inhibitor that selectively targets VEGFR2, EphB4, and PDGFRβ

D. Brittelli, L. Miller, M. Velleca, 2010 .

P. Bridgman, L. Elkin, 2000, Journal of neurocytology.

Abstract B11: Preclinical and preliminary phase 1 trial results of JI‐101: A novel, oral tyrosine kinase inhibitor that selectively targets VEGFR2, EphB4, and PDGFR

D. Brittelli, L. Miller, M. Velleca, 2009 .

Development of a high-throughput mass spectrometry based analytical method to support an in vitro OATP1B1 inhibition screening assay.

M. Soars, W. Shou, K. Mosure, 2016, Rapid communications in mass spectrometry : RCM.

Challenges and Opportunities in Enabling High-Throughput, Miniaturized High Content Screening.

Martyn Banks, Jonathan O'Connell, Debra Nickischer, 2018, Methods in molecular biology.

Inhibitor scaffolds as new allele specific kinase substrates.

K. Shokat, D. Morgan, J. Blethrow, 2002, Journal of the American Chemical Society.

Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4.

K. Currie, J. Darrow, D. Pippin, 2009, Bioorganic & medicinal chemistry letters.